Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Antibodies and Future Risk of Anogenital Cancer: A Nested Case-Control Study in the European Prospective Investigation Into Cancer and Nutrition Study
Aimée R. Kreimer, Paul Brennan, Krystle A. Lang Kuhs, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 8, pp. 877-884
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

International trends in anal cancer incidence rates
Farhad Islami, Jacques Ferlay, Joannie Lortet‐Tieulent, et al.
International Journal of Epidemiology (2016), pp. dyw276-dyw276
Open Access | Times Cited: 294
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden
Dana Hashim, Eric M. Genden, Marshall R. Posner, et al.
Annals of Oncology (2019) Vol. 30, Iss. 5, pp. 744-756
Open Access | Times Cited: 217
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma
Dana Holzinger, Gunnar Wichmann, Lorena Baboçi, et al.
International Journal of Cancer (2017) Vol. 140, Iss. 12, pp. 2748-2757
Open Access | Times Cited: 108
Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus
Claus Wittekindt, Steffen Wagner, Ayman Bushnak, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 6, pp. 375-382
Open Access | Times Cited: 81
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case‐control study in the Swiss HIV cohort study
Gary M. Clifford, Silvia Franceschi, Olivia Keiser, et al.
International Journal of Cancer (2015) Vol. 138, Iss. 7, pp. 1732-1740
Open Access | Times Cited: 80
The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis
Rei Wakabayashi, Yusuke Nakahama, Nguyễn Hoàng Việt, et al.
Microorganisms (2019) Vol. 7, Iss. 7, pp. 199-199
Open Access | Times Cited: 63
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer
Virginia E. Drake, Carole Fakhry, Melina J. Windon, et al.
Cancer (2021) Vol. 127, Iss. 7, pp. 1029-1038
Open Access | Times Cited: 56
New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors
Lauro Bucchi, Margherita Pizzato, Stefano Rosso, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 389-389
Open Access | Times Cited: 34
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
Hilary A. Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 31, pp. 3613-3622
Open Access | Times Cited: 34
Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis
Krystle A. Lang Kuhs, Devasena Anantharaman, Tim Waterboer, et al.
Cancer Epidemiology Biomarkers & Prevention (2015) Vol. 24, Iss. 4, pp. 683-689
Open Access | Times Cited: 61
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer
Aida Ferreiro-Iglesias, James McKay, Nicole Brenner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations
Elena Sophie Prigge, Magnus von Knebel Doeberitz, Miriam Reuschenbach
Mutation Research/Reviews in Mutation Research (2016) Vol. 772, pp. 51-66
Closed Access | Times Cited: 47
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Gypsyamber D’Souza, Gwendolyn Clemens, Tanya Troy, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 10, pp. 689-700
Open Access | Times Cited: 43
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank
Nicole Brenner, Alexander J. Mentzer, Michael Hill, et al.
EBioMedicine (2020) Vol. 62, pp. 103123-103123
Open Access | Times Cited: 34
Antibodies as biomarkers for cancer risk: a systematic review
Maria J. Monroy‐Iglesias, Silvia Crescioli, Kerri Beckmann, et al.
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 1, pp. 46-63
Open Access | Times Cited: 21
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
Luisa Galati, Jean‐Damien Combes, Florence Le Calvez‐Kelm, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 20
Screening for Cancer in Persons Living with HIV Infection
James J. Goedert, H. Dean Hosgood, Robert J. Biggar, et al.
Trends in cancer (2016) Vol. 2, Iss. 8, pp. 416-428
Open Access | Times Cited: 36
Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review
H. Mirghani, Erich M. Sturgis, Anne Aupérin, et al.
Oral Oncology (2017) Vol. 67, pp. 138-145
Closed Access | Times Cited: 36
Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways
Xin Zhang, Keesiang Lim, Yujia Qiu, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 151-151
Open Access
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment
Yuehan Zhang, Tim Waterboer, Robert I. Haddad, et al.
Oral Oncology (2017) Vol. 67, pp. 77-82
Open Access | Times Cited: 32
Blood-based screening for HPV-associated cancers
Dipon Das, Shun Hirayama, Ling Aye, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening—A Systematic Review and Meta-Analysis
Sara Tous, M.C. Vazquez Guillamet, Tim Waterboer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3437-3437
Open Access | Times Cited: 3
Genomics of Cancer and a New Era for Cancer Prevention
Paul Brennan, Christopher P. Wild
PLoS Genetics (2015) Vol. 11, Iss. 11, pp. e1005522-e1005522
Open Access | Times Cited: 22
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
Julia Brotherton, Mark Jit, Patti E. Gravitt, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 3, pp. 510-517
Open Access | Times Cited: 22
Background and Current Treatment of Squamous Cell Carcinoma of the Anus
Rob Glynne‐Jones, Waqar Saleem, Mark Harrison, et al.
Oncology and Therapy (2016) Vol. 4, Iss. 2, pp. 135-172
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top